Which of the following medications has a narrow therapeutic index and requires serum concentrations to be monitored to prevent harm?

Carvedilol is a non-selective beta-blocker that does not typically require serum concentration monitoring. It has a wider therapeutic index, allowing for a more forgiving dosing regimen, which makes it less critical to monitor levels in the same way as medications with a narrow therapeutic index.

Citalopram is an SSRI (selective serotonin reuptake inhibitor) used primarily for depression and anxiety. While it may have considerations for dosage adjustments, it is not classified as having a narrow therapeutic index. Routine serum level monitoring is not standard practice for citalopram, making it less critical than carbamazepine.

Clindamycin is an antibiotic used to treat various bacterial infections. It has a broader therapeutic index and does not require the monitoring of serum concentrations. While it is important in ensuring adequate dosing for infection control, it does not pose the same risk of toxicity that necessitates serum monitoring as seen with carbamazepine.